Company: IMG
Filing Date: 2025-07-21
Form Type: 10-K
Source: 0001641172-25-020300
Chunk: 543

Company: CIMG Inc.
Filing Date: 2025-07-21
Form: 10-K
Item: Item 3
Chunk 543
---
 of approximately 5,200 shares of Common Stock at an exercise price of $2.77
per share. The warrants have a five year term and are exercisable upon the six-month anniversary of the original issuance date. The Subscription
Shares were issued with a purchase price of $129,636. The company has received purchase price of $129,662.8 on Nov 19, 2023, but the subscription
shares of 46,800 common stocks were not issued as of the date of this report. The company expect to issue 46,800 common stocks to the
accredited investor on September 1, 2025. As of the date of this report, the warrants remains unexcised.

On January 30, 2024, the
Company issued in a private placement to an accredited investor 14,220 shares
of Common Stock, together with warrants to purchase a total of approximately 1,279 shares
of Common Stock at an exercise price of $2.11 per
share. The warrants have a five year term and are exercisable upon the six-month anniversary
of the original issuance date.  The company has received the advance payment of $29,994.2
on January 23, 2024, but the subscription shares of 14,220
common stocks were not issued as of the date of this report. The company expect to issue14,220
common stocks to the accredited investor on September 1, 2025. As of the date of this report, the warrants remains unexcised.

On April 27, 2024, the Company entered into
a convertible note and warrant purchase agreement (the “2024 April Purchase Agreement”) with certain investors (the “Investors”),
providing for the private placement of convertible promissory notes in the aggregate principal amount of $320,000
(the “Notes”) and warrants (the “2024 April Warrants”) to purchase up to an aggregate of 221,147
shares of the Company’s Common Stock, par value $0.00001
per share. Each Warrant has an exercise price of $1.322
per share, which represents the average NOCP for the five trading days immediately preceding the signing of the 2024 April Purchase Agreement
in accordance with the “Minimum Price” requirements
under Nasdaq Listing Rule 5635(d). The Warrants are immediately exercisable and have a two-year term.

On October 18,